ALNY
Ticker
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…Alnylam Pharmaceuticals, Inc. (ALNY), in the Healthcare sector, has 28 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 7 corporate insiders: 0 purchases and 28 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 11 and filed Sep 9. The most active filer was Pushkal Garg with 12 filings.
Add to watchlistFilings, ttm
28
0 buys · 28 sells · 1 late
Traders, ttm
8
1 congress · 7 insiders
Volume, ttmiDollar value disclosed in the window
$45.1M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 11
Filed Sep 9
ADViAverage daily dollar volume
$470.9M
market data
Share price · 12M
$239 (-47.3%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $126.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
PGRecent filings
Cory A BookerSALE
Senator (Spouse)
$8K$1K–15K bracket
Exec Aug 11
Filed Sep 9 David E I PyottSALE Director $1.1M
3,813 sh across 4 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Melissa McLaughlinSALE Chief Human Resources Officer $688K
2,097 sh across 3 lots
Exec Apr 2
Filed Apr 7 · 5:30 PM ET † Tolga TangulerSALE EVP, Chief Commercial Officer $361K
1,117 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Jeffrey V. PoultonSALE EVP, Chief Financial Officer $386K
1,192 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Yvonne GreenstreetSALE Chief Executive Officer $689K
2,130 sh across 4 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Pushkal GargSALE EVP Chief R&D $1.1M
3,521 sh across 6 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Yvonne GreenstreetSALE Chief Executive Officer $2.1M
6,439 sh across 8 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Tolga TangulerSALE EVP, Chief Commercial Officer $236K
721 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Kevin Joseph FitzgeraldSALE CSO & EVP, Head of Research $583K
1,802 sh across 4 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Pushkal GargSALE EVP Chief R&D $821K
2,549 sh across 6 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Jeffrey V. PoultonSALE EVP, Chief Financial Officer $441K
1,351 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Pushkal GargSALE EVP Chief R&D $1.4M
4,360 sh across 3 lots
Exec Feb 27
Filed Mar 2 · 5:30 PM ET Jeffrey V. PoultonSALE EVP, Chief Financial Officer $695K
2,242 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET Kevin Joseph FitzgeraldSALE CSO & EVP, Head of Research $1.3M
4,000 sh across 2 lots
Exec Feb 13
Filed Feb 17 · 5:30 PM ET Tolga TangulerSALE EVP, Chief Commercial Officer $607K
1,959 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET Yvonne GreenstreetSALE Chief Executive Officer $2.2M
6,958 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET Pushkal GargSALE EVP Chief R&D $695K
2,242 sh × $310.08
Exec Feb 13
Filed Feb 17 · 5:30 PM ET Kevin Joseph FitzgeraldSALE CSO & EVP, Head of Research $730K
1,971 sh across 4 lots
Exec Jan 13
Filed Jan 14 · 5:30 PM ET Jeffrey V. PoultonSALE EVP, Chief Financial Officer $384K
1,054 sh across 3 lots
Exec Jan 12
Filed Jan 14 · 5:30 PM ET Yvonne GreenstreetSALE Chief Executive Officer $2.8M
7,845 sh across 11 lots
Exec Jan 12
Filed Jan 14 · 5:30 PM ET Kevin Joseph FitzgeraldSALE CSO & EVP, Head of Research $5.4M
11,903 sh across 9 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET Yvonne GreenstreetSALE Chief Executive Officer $11.5M
25,455 sh across 19 lots
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET Pushkal GargSALE EVP Chief R&D $2.3M
5,170 sh across 10 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET Kevin Joseph FitzgeraldSALE CSO & EVP, Head of Research $702K
1,553 sh across 4 lots
Exec Oct 2 2025
Filed Oct 3 2025 · 5:30 PM ET